Sanofi: Smoker’s lung drug benefit was swift and sustained in trial – ET HealthWorld05/22/2023 majac COPD A similar second COPD trial was launched by Sanofi to underpin the … which is also known as chronic obstructive pulmonary disease (COPD).Share on FacebookTweetFollow usSave